SYK and neoplasm: We demonstrated that genetic deletion or pharmacological inhibition of Syk using R788, skews macrophages in a pro-inflammatory state that leads to further changes in the TME by recruitment of CD8+ T cells and increased cytotoxicity against neuroblastoma tumor cells.